Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
07-2013 | 04-2013 | 01-2013 | 10-2012 | 07-2012 | |
Operating Expenses | 3,054 | 5,477 | 2,181 | 0 | 3,583 |
Operating Income | -3,054 | -5,477 | -2,181 | N/A | -3,583 |
Interest Expense | 143 | 96 | 361 | 0 | 1,045 |
Other Income | 1,601 | 296 | -3,891 | 0 | 1,524 |
Pre-tax Income | -1,595 | -5,277 | -6,433 | 0 | -3,105 |
Income Tax | N/A | N/A | -725 | N/A | N/A |
Net Income Continuous | -1,595 | -5,277 | -5,708 | N/A | -3,105 |
Net Income | $-1,595 | $-5,277 | $-5,708 | $N/A | $-3,105 |
EPS Basic Total Ops | -443.78 | -1,547.23 | -1,979.01 | N/A | -1,427.29 |
EPS Basic Continuous Ops | -400.60 | -1,495.87 | -1,920.40 | N/A | -1,341.85 |
EPS Diluted Total Ops | -443.78 | -1,547.23 | -1,979.01 | N/A | -1,427.29 |
EPS Diluted Continuous Ops | -400.60 | -1,495.87 | -1,920.40 | N/A | -1,341.85 |
EBITDA(a) | $-3,005 | $-5,413 | $-2,115 | $N/A | $-3,312 |